Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaMotzer, Robert ; Alekseev, Boris ; Rha, Sun-Young ; Porta, Camillo ; Eto, Masatoshi ; Powles, Thomas ; Grünwald, Viktor ; Hutson, Thomas E ; Kopyltsov, Evgeny ; Méndez-Vidal, María J ; Kozlov, Vadim ; Alyasova, Anna ; Hong, Sung-Hoo ; Kapoor, Anil ; Alonso Gordoa, Teresa ; Merchan, Jaime R ; Winquist, Eric ; Maroto, Pablo ; Goh, Jeffrey C ; Kim, Miso ; Gurney, Howard ; Patel, Vijay ; Peer, Avivit ; Procopio, Giuseppe ; Takagi, Toshio ; Melichar, Bohuslav ; Rolland, Frederic ; De Giorgi, Ugo ; Wong, Shirley ; Bedke, Jens ; Schmidinger, Manuela ; Dutcus, Corina E ; Smith, Alan D ; Dutta, Lea ; Mody, Kalgi ; Perini, Rodolfo F ; Xing, Dongyuan ; Choueiri, Toni KThe New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEscudier, B ; Porta, C ; Schmidinger, M ; Rioux-Leclercq, N ; Bex, A ; Khoo, V ; Grünwald, V ; Gillessen, S ; Horwich, AAnnals of oncology, 2019-05, Vol.30 (5), p.706-720 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell CarcinomaRini, Brian I ; Plimack, Elizabeth R ; Stus, Viktor ; Gafanov, Rustem ; Hawkins, Robert ; Nosov, Dmitry ; Pouliot, Frédéric ; Alekseev, Boris ; Soulières, Denis ; Melichar, Bohuslav ; Vynnychenko, Ihor ; Kryzhanivska, Anna ; Bondarenko, Igor ; Azevedo, Sergio J ; Borchiellini, Delphine ; Szczylik, Cezary ; Markus, Maurice ; McDermott, Raymond S ; Bedke, Jens ; Tartas, Sophie ; Chang, Yen-Hwa ; Tamada, Satoshi ; Shou, Qiong ; Perini, Rodolfo F ; Chen, Mei ; Atkins, Michael B ; Powles, ThomasThe New England journal of medicine, 2019-03, Vol.380 (12), p.1116-1127 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialChoueiri, Toni K, Dr ; Escudier, Bernard, MD ; Powles, Thomas, Prof ; Tannir, Nizar M, Prof ; Mainwaring, Paul N, MD ; Rini, Brian I, Prof ; Hammers, Hans J, MD ; Donskov, Frede, MD ; Roth, Bruce J, Prof ; Peltola, Katriina, MD ; Lee, Jae Lyun, Prof ; Heng, Daniel Y C, MD ; Schmidinger, Manuela, Prof ; Agarwal, Neeraj, MD ; Sternberg, Cora N, Prof ; McDermott, David F, MD ; Aftab, Dana T, PhD ; Hessel, Colin, MS ; Scheffold, Christian, MD ; Schwab, Gisela, MD ; Hutson, Thomas E, Prof ; Pal, Sumanta, MD ; Motzer, Robert J, ProfThe lancet oncology, 2016-07, Vol.17 (7), p.917-927 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell CarcinomaMotzer, Robert J ; Penkov, Konstantin ; Haanen, John ; Rini, Brian ; Albiges, Laurence ; Campbell, Matthew T ; Venugopal, Balaji ; Kollmannsberger, Christian ; Negrier, Sylvie ; Uemura, Motohide ; Lee, Jae L ; Vasiliev, Aleksandr ; Miller, Wilson H ; Gurney, Howard ; Schmidinger, Manuela ; Larkin, James ; Atkins, Michael B ; Bedke, Jens ; Alekseev, Boris ; Wang, Jing ; Mariani, Mariangela ; Robbins, Paul B ; Chudnovsky, Aleksander ; Fowst, Camilla ; Hariharan, Subramanian ; Huang, Bo ; di Pietro, Alessandra ; Choueiri, Toni KThe New England journal of medicine, 2019-03, Vol.380 (12), p.1103-1115 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaMotzer, Robert J ; Escudier, Bernard ; McDermott, David F ; George, Saby ; Hammers, Hans J ; Srinivas, Sandhya ; Tykodi, Scott S ; Sosman, Jeffrey A ; Procopio, Giuseppe ; Plimack, Elizabeth R ; Castellano, Daniel ; Choueiri, Toni K ; Gurney, Howard ; Donskov, Frede ; Bono, Petri ; Wagstaff, John ; Gauler, Thomas C ; Ueda, Takeshi ; Tomita, Yoshihiko ; Schutz, Fabio A ; Kollmannsberger, Christian ; Larkin, James ; Ravaud, Alain ; Simon, Jason S ; Xu, Li-An ; Waxman, Ian M ; Sharma, PadmaneeThe New England journal of medicine, 2015-11, Vol.373 (19), p.1803-1813 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerDerosa, L. ; Hellmann, M.D. ; Spaziano, M. ; Halpenny, D. ; Fidelle, M. ; Rizvi, H. ; Long, N. ; Plodkowski, A.J. ; Arbour, K.C. ; Chaft, J.E. ; Rouche, J.A. ; Zitvogel, L. ; Zalcman, G. ; Albiges, L. ; Escudier, B. ; Routy, B.Annals of oncology, 2018-06, Vol.29 (6), p.1437-1444 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trialPowles, Thomas ; Plimack, Elizabeth R ; Soulières, Denis ; Waddell, Tom ; Stus, Viktor ; Gafanov, Rustem ; Nosov, Dmitry ; Pouliot, Frédéric ; Melichar, Bohuslav ; Vynnychenko, Ihor ; Azevedo, Sergio J ; Borchiellini, Delphine ; McDermott, Raymond S ; Bedke, Jens ; Tamada, Satoshi ; Yin, Lina ; Chen, Mei ; Molife, L Rhoda ; Atkins, Michael B ; Rini, Brian IThe lancet oncology, 2020-12, Vol.21 (12), p.1563-1573 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell CarcinomaChoueiri, Toni K ; Tomczak, Piotr ; Park, Se Hoon ; Venugopal, Balaji ; Ferguson, Thomas ; Chang, Yen-Hwa ; Hajek, Jaroslav ; Symeonides, Stefan N ; Lee, Jae Lyun ; Sarwar, Naveed ; Thiery-Vuillemin, Antoine ; Gross-Goupil, Marine ; Mahave, Mauricio ; Haas, Naomi B ; Sawrycki, Piotr ; Gurney, Howard ; Chevreau, Christine ; Melichar, Bohuslav ; Kopyltsov, Evgeniy ; Alva, Ajjai ; Burke, John M ; Doshi, Gurjyot ; Topart, Delphine ; Oudard, Stephane ; Hammers, Hans ; Kitamura, Hiroshi ; Bedke, Jens ; Perini, Rodolfo F ; Zhang, Pingye ; Imai, Kentaro ; Willemann-Rogerio, Jaqueline ; Quinn, David I ; Powles, ThomasThe New England journal of medicine, 2021-08, Vol.385 (8), p.683-694 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trialRini, Brian I ; Powles, Thomas ; Atkins, Michael B ; Escudier, Bernard ; McDermott, David F ; Suarez, Cristina ; Bracarda, Sergio ; Stadler, Walter M ; Donskov, Frede ; Lee, Jae Lyun ; Hawkins, Robert ; Ravaud, Alain ; Alekseev, Boris ; Staehler, Michael ; Uemura, Motohide ; De Giorgi, Ugo ; Mellado, Begoña ; Porta, Camillo ; Melichar, Bohuslav ; Gurney, Howard ; Bedke, Jens ; Choueiri, Toni K ; Parnis, Francis ; Khaznadar, Tarik ; Thobhani, Alpa ; Li, Shi ; Piault-Louis, Elisabeth ; Frantz, Gretchen ; Huseni, Mahrukh ; Schiff, Christina ; Green, Marjorie C ; Motzer, Robert JThe Lancet (British edition), 2019-06, Vol.393 (10189), p.2404-2415 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |